Article Details

BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine ...

Retrieved on: 2022-05-18 18:06:01

Tags for this article:

Click the tags to see associated articles and topics

BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine .... View article details on HISWAI: https://www.prnewswire.com/il/news-releases/biovaxys-confirms-first-clinical-site-and-principal-investigators-for-ovarian-cancer-vaccine-trial-and-enters-into-second-tumor-cell-supply-agreement-866522578.html

Excerpt

VANCOUVER, BC, May 18, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV; FRA: 5LB; OTCQB: BVAXF) ("BioVaxys" or "Company"), ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up